Skip to main content
. 2018 Feb 1;34(2):193–205. doi: 10.1089/aid.2017.0121

FIG. 2.

FIG. 2.

Local and systemic solicited adverse events. Total number of reported events (A) after three HIV-DNA immunizations combined and (B) after two HIV-MVA boosts combined, in the lower dose (600 μg) and higher dose (1,200 μg) HIV-DNA recipients and placebos.